Concept explainers
(a)
Interpretation:
The effect of enzyme mutation on enzyme activity with varying concentrations of carnitine must be determined.
The KM and Vmax values of wild-type and mutant enzymes must be determined.
Concept introduction:
Carnitine palmitoyl transferase I is a mitochondrial enzyme, which forms acyl carnitine by catalyzing the reaction between acyl CoA, and l-carnitine. This allows the transfer of fatty acid chain from cytosol to the mitochondria of the cell. there are three isoforms of CPT I enzyme, CPT1A, CPT1B, and CPT1C.
(b)
Interpretation:
The effect of enzyme mutation on enzyme activity with varying concentrations of palmitoyl CoA must be determined.
The KM and Vmax values of wild-type and mutant enzymes must be determined.
Concept introduction:
Carnitine palmitoyl transferase I is a mitochondrial enzyme, which forms acyl carnitine by catalyzing the reaction between acyl CoA, and l-carnitine. This allows the transfer of fatty acid chain from cytosol to the mitochondria of the cell. there are three isoforms of CPT I enzyme, CPT1A, CPT1B, and CPT1C.
(c)
Interpretation:
The enzyme that is more sensitive to malonyl CoA inhibition must be determined.
Concept introductionCarnitine palmitoyl transferase I is a mitochondrial enzyme, which forms acyl carnitine by catalyzing the reaction between acyl CoA, and l-carnitine. This allows the transfer of fatty acid chain from cytosol to the mitochondria of the cell. there are three isoforms of CPT I enzyme, CPT1A, CPT1B, and CPT1C.
(d)
Interpretation:
Effect of 100 µM palmitoyl CoA, 100 µM carnitine, and malonyl CoA 10µM on mutant enzyme and wild type enzyme must be determined.
Concept introduction:
Carnitine palmitoyl transferase I is a mitochondrial enzyme, which forms acyl carnitine by catalyzing the reaction between acyl CoA, and l-carnitine. This allows the transfer of fatty acid chain from cytosol to the mitochondria of the cell. there are three isoforms of CPT I enzyme, CPT1A, CPT1B, and CPT1C.
(e)
Interpretation:
Role of glutamate 3 in CPTI function should be determined.
Concept introduction:
Carnitine palmitoyl transferase I is a mitochondrial enzyme, which forms acyl carnitine by catalyzing the reaction between acyl CoA, and l-carnitine. This allows the transfer of fatty acid chain from cytosol to the mitochondria of the cell. there are three isoforms of CPT I enzyme, CPT1A, CPT1B, and CPT1C.
Want to see the full answer?
Check out a sample textbook solutionChapter 22 Solutions
Biochemistry (Looseleaf)
- - Keto counterparts. Name the a-ketoacida-ketoacid that is formed by the transamination of each of the following amino acids: Co, a. Alanine b. Leucine c. Aspartate d. Phenylalanine e. Glutamate f. Tyrosinearrow_forwardPernicious anemia. Purine biosynthesis is impaired by vitamin B12 B12 deficiency. Why? How might fatty acid and amino acid metabolism also be affected bya vitamin B12B12 deficiency?arrow_forwardInducers and Inhibitors of AEP. Short peptides such as legumain stabilization and activity modulation (LSAM) domain and αvβ3 integrin could enhance the activity of AEP. LSAM domain known as the prodomain of AEP blocks substrate binding before activation. This prodomain has a helical structure and two independent peptides. One is an activation peptide (AP, K287 to N323), and the other is a LSAM domain. LSAM domain remains even after AP is cleaved and released from protease at neutral pH via electrostatic interaction. AEP without LSAM domain has a lower melting temperature than AEP with LSAM domain [77, 117]. Another short peptide, αvβ3 integrin, can directly interact with AEP, and after forming a complex, the optimal pH for AEP activity is increased from 5.5 to 6.0. It indicates that αvβ3 binding could induce conformational stabilization of AEP accompanied by deprotonated C189. αvβ3 does not directly interact with the AEP active site; however, AEP docks to the αvβ3 RGD-binding site…arrow_forward
- disease. As such, a frontline treatment for Type 2 diabetes is the drug metformin, which acts indirectly to inhibit gluconeogenesis in the liver. You are a research biochemist who would like to develop new drugs that act to directly inhibit gluconeogenesis. You have just gained access to a library of thousands of small molecules of unknown activity, and you would like to identify lead compounds that have specific inhibitory activity against steps in the gluconeogenesis pathway. (a) into PEP in order to screen for inhibitors of enzymes specific to gluconeogenesis. Which enzymes do you need to purify, what cofactors and allosteric effectors do they require, and which reactants do you need to add to reconstitute the reactions for the first bypass? Which intermediates and products are generated? Your first approach is to reconstitute the initial set of bypass reactions that convert pyruvate (b) vitro reconstitution? What additional steps and enzymes are required in liver cells but are…arrow_forwardATP yield. Each of the following molecules is processed by glycolysis to lactate. How much ATP is generated from each molecule?arrow_forward1G. Please help me in detail. For Molecular Mechanism of ATP versus GTP selectivity of adenylate kinase, Write an expression for the reaction velocity.arrow_forward
- The Cori Cycle. Before vigorous exercise (at rest) the level of blood lactate is at its normal level (about 25 mM). During a 400 m sprint, the value rises sharply in less than a few minutes to about 200 mM and then declines slowly to around 40 mM over 60 mins after the sprint. a. Discuss (or illustrate) the pathway and reactions that cause the rapid increase in lactate concentration during the sprint. b. What causes the slow decline in lactate concentration after the sprint? Why does the decrease occur more slowly than the rapid increase? c. What enzymatic reaction is responsible for maintaining the lactate concentration above zero at recovery after the sprint?arrow_forwardSelect all that apply. What is true about the conformational aspects of coupling? O The proton gradient is involved in the release of bound ATP from the synthase as a result of conformational change. O The conformational states interconvert as a result of proton flux through the synthase. There are two sites for substrate on the synthase and two possible conformational states: open (0) and tight-binding (T). Dinitrophenol binds to and inhibits ATP synthase conformational changes, thus inhibiting ATP synthesis. The Fo portion of ATP synthase acts as a rotary motor.arrow_forwardDraw TCA Cycle. Please make sure to state all the enzymes and co-factors for each step of the pathway.arrow_forward
- Using the ActiveModel for aldose reductase, describe the structure of the TIM barrel motif and the structure and location of the active site.arrow_forwardI. Active site analysis. Below is a diagram of a putative active site for Monoamine oxidase. As we learned, the purpose of tertiary structure is to form a scaffold so you can orient just a few amino acids in the right orientation to promote binding and/or catalysis. The position where this occurs is the active site. The amino acid architecture of an active site is designed to bind substrates. Amino acid side chains are capable of hydrogen bonding, ionic and hydrophobic interactions. Fill in each amino acid that you think is suitable for interacting with the part of the substrate it is closest to. Assume the pH will be at 7.0 a.a.#1 a.a.#2 a.a.#6 HO Lond NH₂ НО a.a.#5 OH a.a.#3 a.a.#4arrow_forwardEnteric bacteria .lactic acid, and propionic bacteria have distinctive metabolic traits that can be used to characterized and identify these organisms .Describe the metabolic characteristics of these organisms name a genus that belong to each group, initiated in what way these organisms can be differentiated.arrow_forward
- BiochemistryBiochemistryISBN:9781305577206Author:Reginald H. Garrett, Charles M. GrishamPublisher:Cengage Learning